COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,900 Articles (22,568 medRxiv, 8,332 bioRxiv)

Most recent first Previous |  Page 2504: Articles 25031-25040  | Next

Diagnostic technology for COVID-19: comparative evaluation of antigen and serology-based SARS-CoV-2 immunoassays, and contact tracing solutions for potential use as at-home products
Jorfi, M., Luo, N. M., Hazra, A., Herisson, F., Miller, G., Toombs, J. A., Walt, D. R., Bonato, P., Ahmad, R., COVID-19 Direct-to-Consumer Task Force Investigators
10.1101/2020.06.25.20140236 — Posted: 2020-06-29
Silk fabric as a protective barrier for personal protective equipment and as a functional material for face coverings during the COVID-19 pandemic
Parlin, A. F., Stratton, S. M., Culley, T. M., Guerra, P. A.
10.1101/2020.06.25.20136424 — Posted: 2020-06-29 Discussion: Onsite
Cirrhosis and COVID-19: a fatal case of viral peritonitis and disseminated infection
Passarelli, V. C., Perosa, A., Luna, L., Conte, D., Nascimento, O., Ota-Arakaki, J., Bellei, N.
10.1101/2020.06.25.20139998 — Posted: 2020-06-29
Efficacy and Safety of Remdesivir for COVID-19 Treatment: An Analysis of Randomized, Double-Blind, Placebo-Controlled Trials
Zhu, Y., Teng, Z., Yang, L., Xu, S., Liu, J., Teng, Y., Hao, Q., Zhao, D., Li, X., Lu, S., Zeng, Y.
10.1101/2020.06.22.20136531 — Posted: 2020-06-29
SUPERSPREADING AS A REGULAR FACTOR OF THE COVID-19 PANDEMIC
Dimaschko, J.
10.1101/2020.06.29.20138008 — Posted: 2020-06-29
SARS-CoV-2 seroprevalence in the municipality of Sao Paulo, Brazil, ten weeks after the first reported case
Tess, B. H., Granato, C. F. H., Alves, M. C. G. P., Pintao, M. C., Rizzatti, E., Nunes, M. C., Reinach, F. C.
10.1101/2020.06.29.20142331 — Posted: 2020-06-29 Discussion: Onsite
The therapeutic effectiveness of Convalescent plasma therapy on treating COVID-19 patients residing in respiratory care units in hospitals in Baghdad, Iraq
Rasheed, A. M., Ftak, D. F., Hashim, H. A., Maulood, M. F., Kabah, K. K., Abdulamir, A. S.
10.1101/2020.06.24.20121905 — Posted: 2020-06-29 Discussion: Onsite
Differential occupational risks to healthcare workers from SARS-CoV-2: A prospective observational study
Eyre, D. W., Lumley, S. F., O'Donnell, D., Campbell, M., Sims, E., Lawson, E., Warren, F., James, T. J., Cox, S., Howarth, A., Doherty, G., Hatch, S. B., Kavanagh, J., Chau, K. K., Fowler, P. W., Swann, J., Volk, D., Yang-Turner, D., Stoesser, N. E., Matthews, P. C., Dudareva, M., Davies, T., Shaw, R. H., Peto, L., Downs, L. O., Vogt, A., Amini, A., Young, B. C., Drennan, P., Mentzer, A. J., Skelly, D., Karpe, F., Neville, M. J., Andersson, M., Brent, A. J., Jones, N., Martins Ferreira, L., Christott, T., Marsden, B., Hoosdally, S., Cornall, R., Crook, D. W., Stuart, D., Screaton, G., Oxford University Hospitals Staff Testing Group, , Peto, T. E., Holthof, B., O'Donnell, A.-M., Ebner, D., Conlon, C. P., Jeffery, K., Walker, T. M.
10.1101/2020.06.24.20135038 — Posted: 2020-06-29 Discussion: Onsite
Effects of Anticoagulants and Corticosteroids therapy in patients affected by severe COVID-19 Pneumonia
Sabir, A. M., Alvi, I. A., Alharbi, M., Basabrain, A., Aljundi, M., Almohammadi, G., Almuairfi, Z., Alharbi, R.
10.1101/2020.06.22.20134957 — Posted: 2020-06-29
Sentinel Coronavirus Environmental Monitoring Can Contribute to Detecting Asymptomatic SARS-CoV-2 Virus Spreaders and Can Verify Effectiveness of Workplace COVID-19 Controls
Marshall, D., Bois, F., Jensen, S. K. S., Linde, S. A., Higby, R., Remy-McCort, Y., Murray, S., Dieckelman, B., Sudradjat, F.
10.1101/2020.06.24.20131185 — Posted: 2020-06-29 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).